Skip to main content
Virologica Sinica logoLink to Virologica Sinica
. 2010 Oct 8;25(5):375–380. doi: 10.1007/s12250-010-3144-y

Effects of 1,2,4,6-tetra-O-galloyl-β-D-glucose from P. emblica on HBsAg and HBeAg secretion in HepG2.2.15 cell culture

Yang-fei Xiang 1, Huai-qiang Ju 1, Shen Li 1, Ying-jun Zhang 2, Chong-ren Yang 2, Yi-fei Wang 1,
PMCID: PMC7090425  PMID: 20960184

Abstract

A polyphenolic compound, 1,2,4,6-tetra-O-galloyl-β-D-glucose (1246TGG), was isolated from the traditional Chinese medicine Phyllanthus emblica L. (Euphorbiaceae) and assayed for its potential as an anti-hepatitis B virus (HBV) agent. The cytotoxicity of 1246TGG on HepG2.2.15 as well as HepG2 cells was determined by observing cytopathic effects, and the effects of 1246TGG on secretion of HBsAg and HBeAg in HepG2.2.15 cells were assayed by enzyme immunoassay. Results indicates that treatment with 1246TGG (6.25 μg/mL, 3.13 μg/mL), reduced both HBsAg and HBeAg levels in culture supernatant, yet the inhibitory effects tend to decline with the assay time. This study provides a basis for further investigation of the anti-HBV activity and possible mechanism of action of 1246TGG.

Key words: 1,2,4,6-tetra-O-galloyl-β-D-glucose (1246TGG); Phyllanthus emblica; Euphorbiaceae; HBV; Antiviral agents

Footnotes

Foundation item: Joint Funds of National Natural Science Foundation of China (U0632010).

References

  • 1.Duan D., Li Z., Luo H., et al. Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease. Bioorg Med Chem Lett. 2004;20;14(24):6041–6044. doi: 10.1016/j.bmcl.2004.09.067. [DOI] [PubMed] [Google Scholar]
  • 2.EL-Mekkawy S., Meselhy M. R., Kusumoto I. T., et al. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull. 1995;43(4):641–648. doi: 10.1248/cpb.43.641. [DOI] [PubMed] [Google Scholar]
  • 3.Fukuchi K., Sakagami H., Okuda T., et al. Inhibition of herpes simplex virus infection by tannins and related compounds. Antiviral Res. 1989;11(5–6):285–297. doi: 10.1016/0166-3542(89)90038-7. [DOI] [PubMed] [Google Scholar]
  • 4.Korba B. E., Milman G. A cell culture assay for compounds which inhibit hepatitis B virus replication. Antiviral Res. 1991;15(3):217–228. doi: 10.1016/0166-3542(91)90068-3. [DOI] [PubMed] [Google Scholar]
  • 5.Lançon A., Delmas D., Osman H., et al. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Commun. 2004;316(4):1132–1137. doi: 10.1016/j.bbrc.2004.02.164. [DOI] [PubMed] [Google Scholar]
  • 6.Lançon A, Hanet N, Jannin B, et al. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab Dispos, 35(5): 699–703. [DOI] [PubMed]
  • 7.Lee W.M. Hepatitis B virus infection. N Engl J Med. 1997;337(24):1733–1745. doi: 10.1056/NEJM199712113372406. [DOI] [PubMed] [Google Scholar]
  • 8.Lee S. J., Lee H. K., Jung M. K., et al. In vitro antiviral activity of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose against hepatitis B virus. Biol Pharm Bull. 2006;29(10):2131–2134. doi: 10.1248/bpb.29.2131. [DOI] [PubMed] [Google Scholar]
  • 9.Manabu T., Masayuki T., Yasuo T. Studies on antiviral activity of several hydrolyzable tannins. International congress series. 1985;667:223–224. [Google Scholar]
  • 10.Nakashima H., Ichiyama K., Hirayama F., et al. Sulfated pentagalloyl glucose (Y-ART-3) inhibits HIV replication and cytopathic effects in vitro, and reduces HIV infection in hu-PBL-SCID mice. Antiviral Res. 1996;30(2–3):95–108. doi: 10.1016/0166-3542(95)00903-5. [DOI] [PubMed] [Google Scholar]
  • 11.Sun J., Hou J. L. Management of chronic hepatitis B: experience from China. J Viral Hepatitis. 2010;17(S1):10–17. doi: 10.1111/j.1365-2893.2010.01274.x. [DOI] [PubMed] [Google Scholar]
  • 12.Tiollais P., Pourcel C., Dejean A. The hepatitis B virus. Nature. 1985;317(5):489–495. doi: 10.1038/317489a0. [DOI] [PubMed] [Google Scholar]
  • 13.Xia Q., Xiao P. G., Wang L. W., et al. Ethnopharmacology of Phyllanthus emblica L. China J Chin Mat Med. 1997;22(9):515–518. [PubMed] [Google Scholar]
  • 14.Xiang Y. F., Pei Y., Wang Y. F. Current status of natural products from plants as anti-herpes simplex virus 1 agents. Virol Sin. 2008;23(5):305–314. doi: 10.1007/s12250-008-2962-7. [DOI] [Google Scholar]
  • 15.Yeo S. J., Yun Y. J., Lyu M. A., et al. Respiratory syncytial virus infection induces matrix metal-loproteinase-9 expression in epithelial cells. Arch Virol. 2002;147(2):229–242. doi: 10.1007/s705-002-8316-1. [DOI] [PubMed] [Google Scholar]
  • 16.Zhang J., Li L., Kim S. H., et al. Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose. Pharm Res. 2009;26(9):2066–2080. doi: 10.1007/s11095-009-9932-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zhang L., Wang G., Hou W., et al. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology. 2010;51(2):690–698. doi: 10.1002/hep.23384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhang Y. J., Abe T., Tanaka T., et al. Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica. J Nat Prod. 2001;64(12):1527–1532. doi: 10.1021/np010370g. [DOI] [PubMed] [Google Scholar]

Articles from Virologica Sinica are provided here courtesy of Wuhan Institute of Virology, Chinese Academy of Sciences

RESOURCES